Skip to main content
Equibles

Prahlad Singh

CEO

Revvity, Inc. (RVTY)

Board Member

Revvity, Inc. (RVTY)

Equibles does not estimate personal net worth.

Get an email with a short summary when Revvity, Inc. publishes a filing, an earnings call transcript or a press release.

Get RVTY alerts

About Prahlad Singh

Prahlad Singh is recorded as Board Member at Revvity, Inc. (RVTY) since January 1, 2019 and CEO at Revvity, Inc. (RVTY). The newest filing on record that lists Prahlad Singh as Board Member at Revvity, Inc. (RVTY) is dated March 16, 2026. The proxy statement of Revvity, Inc. reports total compensation of $13,809,549 for Prahlad Singh in fiscal 2025, including a base salary of $1,129,231. Disclosed compensation is on record for 9 fiscal years. Prahlad Singh has spoken on 27 earnings calls and 2 other investor events across 1 company, most recently for Revvity, Inc. on November 3, 2026. Revvity, Inc. is classified in the Diagnostics & Research industry within the Healthcare sector. Other leadership on record at Revvity, Inc. includes Robert F. Friel (CEO), Senior Vice (CFO), Joel S. Goldberg (General Counsel) and 7 others.

Prahlad Singh on recent calls

“I'm pleased to report that Revity delivered exceptionally strong performance in the third quarter, with pro forma organic growth of 7%, exceeding our mid-single-digit expectation.”
CEO, Q3 2026 Revvity Earnings Conference Call ·
“I think, you know, as we've talked about, human cell design is a great token acquisition for our reagents business, and it fits perfectly well with what we've talked about, how our reagents business has been doing good on the preclinical stage.”
CEO, Wells Fargo 21st Annual Healthcare Conference ·
“I'm pleased to report that Revity delivered strong results in the second quarter, with pro forma organic growth of 3%, resulting in total revenue being above the high end of our expectations.”
CEO, Q2 2026 Revvity Earnings Conference Call ·
“Just as we look at the businesses, as you said, we had a great start to the year. You know, on the diagnostic side, reproductive health franchise continues to do very well.”
CEO, Goldman Sachs 47th Annual Global Healthcare Conference ·
“I have several important developments to discuss today. First, I'm really excited to report that Revity delivered strong first quarter results with 3% total company organic growth, demonstrating the resilience and strength of our business.”
CEO, Revvity, Inc. Q1 FY2026 Earnings Call ·

Affiliation history

Company network

Leadership on record at Revvity, Inc.

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2025 Revvity, Inc. (RVTY) $1,129,231 $13,809,549
2024 Revvity, Inc. (RVTY) $1,100,000 $11,926,615
2023 Revvity, Inc. (RVTY) $1,086,539 $9,130,624
2022 Revvity, Inc. (RVTY) $1,050,000 $10,576,998
2021 Revvity, Inc. (RVTY) $1,002,885 $9,661,006
2020 Revvity, Inc. (RVTY) $900,000 $9,017,969
2019 Revvity, Inc. (RVTY) $645,135 $4,116,556
2018 Revvity, Inc. (RVTY) $516,538 $2,057,894
2017 Revvity, Inc. (RVTY) $464,231 $1,808,854

Recent activity

Show 17 earlier activities